Scarica l'app Stockscreener
1,039.78
0.16%
1.66
Argen X Se Adr Borsa (ARGX) Ultime notizie
ETFs Investing in argenx SE Sponsored ADR Stocks - TradingView
Resilient Argenx stock climbs after positive myositis data and fresh analyst targets - Ad-hoc-news.de
RBC Capital raises argenx stock price target on myositis data - Investing.com
Strong Argenx stock extends rally after Vyvgart trial win and analyst target hikes. - Ad-hoc-news.de
Gold Gains 1%; NY Empire State Manufacturing Index Rises In August - Sahm
Citizens raises argenx stock price target to $1,200 on trial results - Investing.com
Argenx's Positive Vyvgart Data in Autoimmune Indication Supports Growth and FB102 Broadens Portfolio - Morningstar
Resilient Argenx stock jumps after positive Vyvgart Phase 3 data - Ad-hoc-news.de
TD Cowen raises argenx stock price target to $1,353 on myositis outlook - Investing.com Australia
ARGX Stock Price, Quote & Chart - ChartMill
European ADRs Started The Week Slightly Higher In US Trading - Finimize
There are notable gap-ups and gap-downs in today's session. - ChartMill
H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Movi - Benzinga
Argx stock hits all-time high at 954.5 USD By Investing.com - Investing.com Canada
argenx SE (ARGX) Stock Price, News, Quote & History - Yahoo Finance
argenx reports positive Phase 3 ALKIVIA results - grafa.com
Zai Lab, argenx report positive phase 3 data for myositis drug - Investing.com India
Why is Argen-X stock surging today? - Investing.com
Why is Argen-X stock surging today? By Investing.com - Investing.com India
Argenx shares jump after positive Phase 3 results in autoimmune myositis trial - Investing.com South Africa
H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday - Sahm
T. Rowe Price (ARGX) discloses 2.68M argenx SE ADRs with 4.3% ownership - Stock Titan
Forte Biosciences earnings on deck as $2.2 billion argenx deal nears - Investing.com
Argenx stock holds near recent highs as half year 2026 update and Forte deal shape outlook - AD HOC NEWS
Weekly Recap: Cash tender offer for Forte and EGM on director appointments - TradingView
Galapagos ADR Representing Ord Shs (LKFT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
argenx launches tender offer for Forte Biosciences at $77 per share - Investing.com
The Charts Reveal Significant Price Movement in Forte Biosciences Stock Ahead of Argenx’s Acquisition Announcement - Barchart.com
Argenx stock price target held at $940 by H.C. Wainwright on acquisition - Investing.com South Africa
Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In June - Benzinga
Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks M - Benzinga
argenx SE (ARGX) stock price, news, quote and history - Yahoo Finance UK
argenx to buy Forte Biosciences in a deal worth $2.2 billion - grafa.com
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Argenx to buy Forte Biosciences for $2.2 billion to expand immunology pipeline - Investing.com UK
Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks Moving Higher On Monday - Sahm
Weekly Recap: Q2 sales and profit surge and Empasiprubart readout schedule - TradingView
argenx SE Sponsored ADR Revenue Breakdown – DUS:1AEA - TradingView
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Brainsway (BWAY) and Argenx Se (ARGX) - The Globe and Mail
argenx SE ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR - TradingView
RBC Capital raises argenx stock price target to $1,025 on strong Vyvgart sales - Investing.com
H.C. Wainwright reiterates argenx stock rating on strong sales - Investing.com
Guggenheim raises argenx stock price target to $1,185 on strong sales - Investing.com
Citizens cuts argenx stock price target to $932 on valuation - Investing.com
Citizens cuts argenx stock price target to $932 on valuation By Investing.com - Investing.com Canada
Argenx's Robust Vyvgart Growth Drives Margin Expansion as Pipeline Advances - Morningstar
European ADRs Slipped In US Trading Late Thursday - Finimize
argenx Q2 2026 slides: 60% sales growth, seronegative gMG expansion - Investing.com
argenx ADR earnings beat by $0.97, revenue topped estimates - Investing.com
Argenx soars on strong Vyvgart sales, beating estimates By Investing.com - Investing.com Canada
Argenx shares jump on Vyvgart sales beat, pipeline readouts ahead By Investing.com - Investing.com Nigeria
Argenx soars on strong Vyvgart sales, beating estimates - Investing.com
argenx SE (ARGNF) Q2 2026 Earnings Call Highlights: Robust Growth and Strategic Advances By GuruFocus - Investing.com Canada
BR:A1RG34 Stock Latest News - TipRanks
Argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update - marketscreener.com
Argenx Se (ARGX) Receives a Buy from Guggenheim - The Globe and Mail
ARGENX : Receives a Buy rating from Deutsche Bank - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
8.86%
1.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):